COMMUNIQUÉS West-GlobeNewswire

CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13
06/05/2019
BERKELEY HEIGHTS, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Monday, May 13th, 2019
06/05/2019
CORAL GABLES, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
VBL Therapeutics to Report First Quarter 2019 Financial Results on May 15
06/05/2019
TEL AVIV, Israel, May 06, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Foamix Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019
06/05/2019
REHOVOT, Israel, and BRIDGEWATER, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), clinical stage specialty pharmaceutical company focused on developing and commercializing [...]
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares Its $0.27 Per Share Dividend
06/05/2019
DELRAY BEACH, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the fiscal year ended March 31, 2019. Net sales for the quarter ended March 31, 2019 [...]
Progressive Care Inc. and Frostime, LLC Launch Cold Chain Integrity Pilot Program
06/05/2019
MIAMI, May 06, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has launched a cold chain integrity pilot program with [...]
electroCore Selected for Innovation and Technology Payment Program Through NHS England
06/05/2019
gammaCore™ chosen by NHS England to be funded by the Innovation and Technology Payment Program (ITP) for the period of April 2019 to April 2020 to support adoption in the U.K. LONDON and BASKING RIDGE, N.J., May 06, [...]
Alder BioPharmaceuticals® Presents New Data Demonstrating Consistent, Early and Robust Prevention with Eptinezumab for Episodic and Chronic Migraine across Four Clinical Trials
06/05/2019
Data presented at the 2019 American Academy of Neurology (AAN) meeting demonstrate more than 50% of patients achieved rapid onset of migraine prevention with eptinezumab on Day 1 across four clinical trials BOTHELL, [...]
ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Decision
06/05/2019
EDISON, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
GBT Announces New Employment Inducement Grants
06/05/2019
SOUTH SAN FRANCISCO, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on May 1, 2019, the compensation committee of GBT’s board of directors granted nine [...]
Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update
06/05/2019
EMA grants PRIME eligibility for KB103 (bercolagene telserpavec) to treat dystrophic epidermolysis bullosa Krystal Biotech announces five presentations of clinical and preclinical data at the Society for Investigative [...]
RavenQuest Awarded its First Cannabis Sales License from Health Canada
06/05/2019
VANCOUVER, British Columbia, May 06, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
iCAD Appoints R. Scott Areglado as Chief Financial Officer
06/05/2019
NASHUA, N.H., May 06, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today appointed R. Scott Areglado as Chief [...]
Athenex Announces $100 Million Private Placement
06/05/2019
BUFFALO, N.Y., May 06, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
BioSig Technologies Completes Patient Cases at Indiana University
06/05/2019
Third Center to Use PURE EP(tm) System Santa Monica, CA, May 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform [...]
Engage Therapeutics Presents Data from Part 1, Open-label Run-in of StATES Phase 2b Study of Staccato® Alprazolam at 2019 American Academy of Neurology Annual Meeting
06/05/2019
– Eight (8) patients with predictable generalized or focal epileptic seizures treated with Staccato alprazolam – – 62.5 percent of patients respond with cessation of seizure activity within two minutes of therapy [...]
Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates
06/05/2019
WALTHAM, Mass., May 06, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
06/05/2019
NEWTOWN, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Adaptimmune Reports First Quarter 2019 Financial Results
06/05/2019
- Clinical update issued in a separate announcement - - Financial guidance updated: funded into Q3 2020 - PHILADELPHIA and OXFORD, United Kingdom, May 06, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: [...]

Pages